共有 471 页
品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|
罗恩 | R132842-1mg | 1mg | 5~7个工作日 |
1-(7-甲基-2-苯基咪唑并[1,2-a]吡啶-3-基... 1-(7-Methyl-2-phenylimidazo[... |
98% |
|
|
罗恩 | R132842-5mg | 5mg | 5~7个工作日 |
1-(7-甲基-2-苯基咪唑并[1,2-a]吡啶-3-基... 1-(7-Methyl-2-phenylimidazo[... |
98% |
|
|
罗恩 | R132842-10mg | 10mg | 5~7个工作日 |
1-(7-甲基-2-苯基咪唑并[1,2-a]吡啶-3-基... 1-(7-Methyl-2-phenylimidazo[... |
98% |
|
|
罗恩 | R132842-25mg | 25mg | 5~7个工作日 |
1-(7-甲基-2-苯基咪唑并[1,2-a]吡啶-3-基... 1-(7-Methyl-2-phenylimidazo[... |
98% |
|
|
罗恩 | R132842-50mg | 50mg | 5~7个工作日 |
1-(7-甲基-2-苯基咪唑并[1,2-a]吡啶-3-基... 1-(7-Methyl-2-phenylimidazo[... |
98% |
|
|
阿拉丁 | I412539-25mg | 25mg | 现货 |
IRAK4-IN-4 IRAK4-IN-4 |
≥98% |
|
|
阿拉丁 | I412539-5mg | 5mg | 现货 |
IRAK4-IN-4 IRAK4-IN-4 |
≥98% |
|
|
阿拉丁 | I412539-100mg | 100mg | 现货 |
IRAK4-IN-4 IRAK4-IN-4 |
≥98% |
|
|
阿拉丁 | I412539-50mg | 50mg | 现货 |
IRAK4-IN-4 IRAK4-IN-4 |
≥98% |
|
|
阿拉丁 | I422266-1ml | 1ml | 现货 |
IRAK4-IN-4 IRAK4-IN-4 |
10mM in DMSO |
|
|
凯为 | JZ01KLAZ-1mg | 1mg | 现货 |
1-(7-甲基-2-苯基咪唑并[1,2-a]吡啶-3-基... 1-(7-Methyl-2-phenylimidazo[... |
98% |
|
|
凯为 | JZ01KLAZ-5mg | 5mg | 现货 |
1-(7-甲基-2-苯基咪唑并[1,2-a]吡啶-3-基... 1-(7-Methyl-2-phenylimidazo[... |
98% |
|
|
凯为 | JZ01KLAZ-10mg | 10mg | 现货 |
1-(7-甲基-2-苯基咪唑并[1,2-a]吡啶-3-基... 1-(7-Methyl-2-phenylimidazo[... |
98% |
|
|
凯为 | JZ01KLAZ-25mg | 25mg | 现货 |
1-(7-甲基-2-苯基咪唑并[1,2-a]吡啶-3-基... 1-(7-Methyl-2-phenylimidazo[... |
98% |
|
|
凯为 | JZ01KLAZ-50mg | 50mg | 现货 |
1-(7-甲基-2-苯基咪唑并[1,2-a]吡啶-3-基... 1-(7-Methyl-2-phenylimidazo[... |
98% |
|
|
凯为 | JZ01KLAZ-100mg | 100mg | 现货 |
1-(7-甲基-2-苯基咪唑并[1,2-a]吡啶-3-基... 1-(7-Methyl-2-phenylimidazo[... |
98% |
|
|
毕得 | BD01171407-5mg | 5mg | 现货 |
1-(7-甲基-2-苯基咪唑并[1,2-a]吡啶-3-基... 1-(7-Methyl-2-phenylimidazo[... |
99% |
|
|
毕得 | BD01171407-10mg | 10mg | 现货 |
1-(7-甲基-2-苯基咪唑并[1,2-a]吡啶-3-基... 1-(7-Methyl-2-phenylimidazo[... |
99% |
|
|
毕得 | BD01171407-25mg | 25mg | 现货 |
1-(7-甲基-2-苯基咪唑并[1,2-a]吡啶-3-基... 1-(7-Methyl-2-phenylimidazo[... |
99% |
|
|
毕得 | BD01171407-50mg | 50mg | 现货 |
1-(7-甲基-2-苯基咪唑并[1,2-a]吡啶-3-基... 1-(7-Methyl-2-phenylimidazo[... |
99% |
|
|
毕得 | BD01171407-100mg | 100mg | 现货 |
1-(7-甲基-2-苯基咪唑并[1,2-a]吡啶-3-基... 1-(7-Methyl-2-phenylimidazo[... |
99% |
|
|
毕得 | BD01171407-1mg | 1mg | 现货 |
1-(7-甲基-2-苯基咪唑并[1,2-a]吡啶-3-基... 1-(7-Methyl-2-phenylimidazo[... |
99% |
|
|
源叶 | S23356-5mg | 5mg | 现货 |
IRAK4-IN-4 IRAK4-IN-4 |
98% |
|
|
源叶 | S23356-10mg | 10mg | 现货 |
IRAK4-IN-4 IRAK4-IN-4 |
98% |
|
|
源叶 | S23356-25mg | 25mg | 现货 |
IRAK4-IN-4 IRAK4-IN-4 |
98% |
|
|
源叶 | S23356-100mg | 100mg | 期货,请咨询 |
IRAK4-IN-4 IRAK4-IN-4 |
98% |
|
|
源叶 | T96586-1ml | 1ml | 期货,请咨询 |
IRAK4-IN-4 IRAK4-IN-4 |
10mM in DMSO |
|
|
Target Mol | T11673-200mg | 200mg | 现货 |
化合物 IRAK4-IN-4 IRAK4-IN-4 |
99.52% |
|
|
Target Mol | T11673-50mg | 50mg | 现货 |
化合物 IRAK4-IN-4 IRAK4-IN-4 |
99.52% |
|
|
Target Mol | T11673-100mg | 100mg | 现货 |
化合物 IRAK4-IN-4 IRAK4-IN-4 |
99.52% |
|
|
Target Mol | T11673-10mg | 10mg | 现货 |
化合物 IRAK4-IN-4 IRAK4-IN-4 |
99.52% |
|
|
Target Mol | T11673-5mg | 5mg | 现货 |
化合物 IRAK4-IN-4 IRAK4-IN-4 |
99.52% |
|
|
Target Mol | T11673-25mg | 25mg | 现货 |
化合物 IRAK4-IN-4 IRAK4-IN-4 |
99.52% |
|
|
Target Mol | T11673-1mg | 1mg | 现货 |
化合物 IRAK4-IN-4 IRAK4-IN-4 |
99.52% |
|
|
Target Mol | T11673-1mL | 1mL | 现货 |
化合物 IRAK4-IN-4 IRAK4-IN-4 |
99.52% |
|
|
Am | A1216693-5mg | 5mg | 现货 |
IRAK4-IN-4 IRAK4-IN-4 |
98% |
|
|
Am | A1216693-50mg | 50mg | 现货 |
IRAK4-IN-4 IRAK4-IN-4 |
98% |
|
|
Am | A1216693-25mg | 25mg | 现货 |
IRAK4-IN-4 IRAK4-IN-4 |
98% |
|
|
Am | A1216693-10mg | 10mg | 现货 |
IRAK4-IN-4 IRAK4-IN-4 |
98% |
|
|
Am | A1216693-1mg | 1mg | 现货 |
IRAK4-IN-4 IRAK4-IN-4 |
98% |
|
|
MCE | HY-114181-25mg | 25mg | 现货 |
IRAK4-IN-4 IRAK4-IN-4 |
99.85% |
|
|
MCE | HY-114181-10mg | 10mg | 现货 |
IRAK4-IN-4 IRAK4-IN-4 |
99.85% |
|
|
MCE | HY-114181-10mM*1mL | 10mM*1mL | 现货 |
IRAK4-IN-4 IRAK4-IN-4 |
99.85% |
|
|
MCE | HY-114181-5mg | 5mg | 现货 |
IRAK4-IN-4 IRAK4-IN-4 |
99.85% |
|
|
MCE | HY-114181-1mg | 1mg | 现货 |
IRAK4-IN-4 IRAK4-IN-4 |
99.85% |
|
|